Phase I Clinical Trial of Dinorencel Injection (or RC19D2 Cell Injection) in the Treatment of CD19-positive Relapsed or Refractory Diffuse Large B-cell Lymphoma
Latest Information Update: 29 Aug 2024
At a glance
- Drugs Denocabtagene Ciloleucel (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Adverse reactions
- Sponsors Beijing Yongtai Ruike Biotechnology
Most Recent Events
- 29 Sep 2023 New trial record